{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T22:15:23Z","timestamp":1791497723843,"version":"4.3.4"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2017,11,25]],"date-time":"2017-11-25T00:00:00Z","timestamp":1511568000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","award":["2011\/23352-4"],"award-info":[{"award-number":["2011\/23352-4"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","award":["2013\/22480-4"],"award-info":[{"award-number":["2013\/22480-4"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["305182\/2014-5"],"award-info":[{"award-number":["305182\/2014-5"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pflugers Arch - Eur J Physiol"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1007\/s00424-017-2088-6","type":"journal-article","created":{"date-parts":[[2017,11,25]],"date-time":"2017-11-25T18:00:16Z","timestamp":1511632816000},"page":"549-558","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["AT1 receptor blockage impairs NF-\u03baB activation mediated by thyroid hormone in cardiomyocytes"],"prefix":"10.1007","volume":"470","author":[{"given":"Ana Paula Cremasco","family":"Takano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalia","family":"Senger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolina Demarchi","family":"Munhoz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Luiza Morais","family":"Barreto-Chaves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,11,25]]},"reference":[{"issue":"1","key":"2088_CR1","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1073\/pnas.1318115111","volume":"111","author":"V Alverdi","year":"2014","unstructured":"Alverdi V, Hetrick B, Joseph S, Komives EA (2014) Direct observation of a transient ternary complex during I\u03baB\u03b1-mediated dissociation of NF-\u03baB from DNA. Proc Natl Acad Sci U S A 111(1):225\u2013230. \nhttps:\/\/doi.org\/10.1073\/pnas.1318115111","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"2088_CR2","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.mce.2010.12.018","volume":"333","author":"AS Araujo","year":"2011","unstructured":"Araujo AS, Diniz GP, Seibel FE, Branchini G, Ribeiro MF, Brum IS, Khaper N, Barreto-Chaves ML, Bell\u00f3-Klein A (2011) Reactive oxygen and nitrogen species balance in the determination of thyroid hormones-induced cardiac hypertrophy mediated by renin-angiotensin system. Mol Cell Endocrinol 333(1):78\u201384. \nhttps:\/\/doi.org\/10.1016\/j.mce.2010.12.018","journal-title":"Mol Cell Endocrinol"},{"issue":"3-4","key":"2088_CR3","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.vph.2009.10.009","volume":"52","author":"MLM Barreto-Chaves","year":"2010","unstructured":"Barreto-Chaves MLM, Carrillo-Sep\u00falveda MA, Carneiro-Ramos MS, Gomes DG, Diniz GP (2010) The crosstalk between thyroid hormones and the renin\u2013angiotensin system. Vasc Pharmacol 52(3-4):166\u2013170. \nhttps:\/\/doi.org\/10.1016\/j.vph.2009.10.009","journal-title":"Vasc Pharmacol"},{"issue":"11","key":"2088_CR4","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1038\/ki.2008.358","volume":"74","author":"S Billet","year":"2008","unstructured":"Billet S, Aguilar F, Baudry C, Clauser E (2008) Role of angiotensin II AT1 receptor activation in cardiovascular diseases. Kidney Int 74(11):1379\u20131384. \nhttps:\/\/doi.org\/10.1038\/ki.2008.358","journal-title":"Kidney Int"},{"issue":"3","key":"2088_CR5","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1007\/s00395-010-0089-0","volume":"105","author":"MS Carneiro-Ramos","year":"2010","unstructured":"Carneiro-Ramos MS, Diniz GP, Nadu AP, Almeida J, Vieira RL, Santos RA, Barreto-Chaves MLM (2010) Blockage of angiotensin II type 2 receptor prevents thyroxine-mediated cardiac hypertrophy by blocking Akt activation. Basic Res Cardiol 105(3):325\u2013335. \nhttps:\/\/doi.org\/10.1007\/s00395-010-0089-0","journal-title":"Basic Res Cardiol"},{"issue":"10","key":"2088_CR6","doi-asserted-by":"publisher","first-page":"2543","DOI":"10.1002\/jcp.22599","volume":"226","author":"A Chatterjee","year":"2011","unstructured":"Chatterjee A, Mir SA, Dutta D, Mitra A, Pathak K, Sarkar S (2011) Analysis of p53 and NF-\u03baB signaling in modulating the cardiomyocyte fate during hypertrophy. J Cell Physiol 226(10):2543\u20132554. \nhttps:\/\/doi.org\/10.1002\/jcp.22599","journal-title":"J Cell Physiol"},{"issue":"2","key":"2088_CR7","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1016\/j.ecl.2014.02.005","volume":"43","author":"S Danzi","year":"2014","unstructured":"Danzi S, Klein I (2014) Thyroid disease and the cardiovascular system. Endocrinol Metab Clin N Am 43(2):517\u2013528. \nhttps:\/\/doi.org\/10.1016\/j.ecl.2014.02.005","journal-title":"Endocrinol Metab Clin N Am"},{"issue":"1","key":"2088_CR8","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/s00424-006-0192-0","volume":"454","author":"GP Diniz","year":"2007","unstructured":"Diniz GP, Carneiro-Ramos MS, Barreto-Chaves ML (2007) Angiotensin type 1 (AT1) and type 2 (AT2) receptors mediate the increase in TGF-beta1 in thyroid hormone-induced cardiac hypertrophy. Pflugers Arch 454(1):75\u201381. \nhttps:\/\/doi.org\/10.1007\/s00424-006-0192-0","journal-title":"Pflugers Arch"},{"issue":"6","key":"2088_CR9","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1007\/s00395-009-0043-1","volume":"104","author":"GP Diniz","year":"2009","unstructured":"Diniz GP, Carneiro-Ramos MS, Barreto-Chaves ML (2009) Angiotensin type 1 receptor mediates thyroid hormone-induced cardiomyocyte hypertrophy through the Akt\/GSK-3\u03b2\/mTOR signaling pathway. Basic Res Cardiol 104(6):653\u2013667. \nhttps:\/\/doi.org\/10.1007\/s00395-009-0043-1","journal-title":"Basic Res Cardiol"},{"issue":"5","key":"2088_CR10","doi-asserted-by":"publisher","DOI":"10.1007\/s00395-015-0504-7","volume":"110","author":"GP Diniz","year":"2015","unstructured":"Diniz GP, Lino CA, Guedes EC, Moreira Ldo N, Barreto-Chaves ML (2015) Cardiac microRNA-133 is down-regulated in thyroid hormone-mediated cardiac hypertrophy partially via type 1 angiotensin II receptor. Basic Res Cardiol 110(5):49. \nhttps:\/\/doi.org\/10.1007\/s00395-015-0504-7","journal-title":"Basic Res Cardiol"},{"issue":"1","key":"2088_CR11","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1530\/JME-11-0141","volume":"49","author":"GP Diniz","year":"2012","unstructured":"Diniz GP, Takano AP, Bruneto E, Silva FG, Nunes MT, Barreto-Chaves ML (2012) New insight into the mechanisms associated with the rapid effect of T3 on AT1R expression. J Mol Endocrinol 49(1):11\u201320. \nhttps:\/\/doi.org\/10.1530\/JME-11-0141","journal-title":"J Mol Endocrinol"},{"issue":"1-2","key":"2088_CR12","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.mce.2013.04.010","volume":"374","author":"GP Diniz","year":"2013","unstructured":"Diniz GP, Takano APC, Barreto-Chaves ML (2013) MiRNA-208a and miRNA-208b are triggered in thyroid hormone-induced cardiac hypertrophy\u2014role of type 1 angiotensin II receptor (AT1R) on miRNA-208a\/\u03b1-MHC modulation. Mol Cell Endocrinol 374(1-2):117\u2013124. \nhttps:\/\/doi.org\/10.1016\/j.mce.2013.04.010","journal-title":"Mol Cell Endocrinol"},{"issue":"18","key":"2088_CR13","doi-asserted-by":"publisher","first-page":"2319","DOI":"10.1161\/01.CIR.0000164237.58200.5A","volume":"111","author":"C Freund","year":"2005","unstructured":"Freund C, Schmidt-Ullrich R, Baurand A, Dunger S, Schneider W, Loser P, El-Jamali A, Dietz R, Scheidereit C, Bergmann MW (2005) Requirement of nuclear factor-\u03baB in angiotensin II- and isoproterenol-induced cardiac hypertrophy in vivo. Circulation 111(18):2319\u20132325. \nhttps:\/\/doi.org\/10.1161\/01.CIR.0000164237.58200.5A","journal-title":"Circulation"},{"issue":"4","key":"2088_CR14","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1016\/j.yjmcc.2006.07.006","volume":"41","author":"G Hall","year":"2006","unstructured":"Hall G, Hasday JD, Rogers TB (2006) Regulating the regulator: NF-kappaB signaling in heart. J Mol Cell Cardiol 41(4):580\u2013591. \nhttps:\/\/doi.org\/10.1016\/j.yjmcc.2006.07.006","journal-title":"J Mol Cell Cardiol"},{"issue":"1","key":"2088_CR15","doi-asserted-by":"publisher","DOI":"10.1007\/s00395-016-0599-5","volume":"112","author":"J Han","year":"2017","unstructured":"Han J, Zou C, Mei L, Zhang Y, Qian Y, You S, Pan Y, Xu Z, Bai B, Huang W, Liang G (2017) MD2 mediates angiotensin II-induced cardiac inflammation and remodeling via directly binding to Ang II and activating TLR4\/NF-\u03baB signaling pathway. Basic Res Cardiol 112(1):9. \nhttps:\/\/doi.org\/10.1007\/s00395-016-0599-5","journal-title":"Basic Res Cardiol"},{"issue":"5","key":"2088_CR16","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1210\/er.2003-0033","volume":"26","author":"GJ Kahaly","year":"2005","unstructured":"Kahaly GJ, Dillmann WH (2005) Thyroid hormone action in the heart. Endocr Rev 26(5):704\u2013728. \nhttps:\/\/doi.org\/10.1210\/er.2003-0033","journal-title":"Endocr Rev"},{"issue":"15","key":"2088_CR17","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.1161\/CIRCULATIONAHA.106.678326","volume":"116","author":"I Klein","year":"2007","unstructured":"Klein I, Danzi S (2007) Thyroid disease and the heart. Circulation 116(15):1725\u20131735. \nhttps:\/\/doi.org\/10.1161\/CIRCULATIONAHA.106.678326","journal-title":"Circulation"},{"key":"2088_CR18","first-page":"H593","volume":"273","author":"H Kobori","year":"1997","unstructured":"Kobori H, Ichihara A, Suzuki H, Takenaka T, Miyashita Y, Hayashi M, Saruta T (1997) Role of the renin-angiotensin system in cardiac hypertrophy induced in rats by hyperthyroidism. Am J Phys 273:H593\u2013H599","journal-title":"Am J Phys"},{"issue":"8","key":"2088_CR19","doi-asserted-by":"publisher","first-page":"H1655","DOI":"10.1152\/ajpheart.00756.2011","volume":"302","author":"S Kumar","year":"2012","unstructured":"Kumar S, Wei C, Thomas CM, Kim IK, Seqqat R, Kumar R, Baker KM, Jones WK, Gupta S (2012) Cardiac-specific genetic inhibition of nuclear factor-\u03baB prevents right ventricular hypertrophy induced by monocrotaline. Am J Physiol Heart Circ Physiol 302(8):H1655\u2013H1666. \nhttps:\/\/doi.org\/10.1152\/ajpheart.00756.2011","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"6","key":"2088_CR20","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1016\/0002-9343(90)90533-J","volume":"88","author":"GS Levey","year":"1990","unstructured":"Levey GS, Klein I (1990) Catecholamine-thyroid hormone interactions and the cardiovascular manifestations of hyperthyroidism. Am J Med 88(6):642\u2013646. \nhttps:\/\/doi.org\/10.1016\/0002-9343(90)90533-J","journal-title":"Am J Med"},{"issue":"2","key":"2088_CR21","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.pharmthera.2010.11.001","volume":"131","author":"A Mackenzie","year":"2011","unstructured":"Mackenzie A (2011) Endothelium-derived vasoactive agents, AT1 receptors and inflammation. Pharmacol Ther 131(2):187\u2013203. \nhttps:\/\/doi.org\/10.1016\/j.pharmthera.2010.11.001","journal-title":"Pharmacol Ther"},{"issue":"3","key":"2088_CR22","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1097\/00005344-199309000-00016","volume":"22","author":"C Marchant","year":"1993","unstructured":"Marchant C, Brown L, Sernia C (1993) Renin\u2013angiotensin system in thyroid dysfunction in rats. J Cardiovasc Pharmacol 22(3):449\u2013455. \nhttps:\/\/doi.org\/10.1097\/00005344-199309000-00016","journal-title":"J Cardiovasc Pharmacol"},{"issue":"1","key":"2088_CR23","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/1476-9255-7-21.","volume":"7","author":"JL Miguel-Carrasco","year":"2010","unstructured":"Miguel-Carrasco JL, Zambrano S, Blanca AJ, Mate A, V\u00e1zquez CM (2010) Captopril reduces cardiac inflammatory markers in spontaneously hypertensive rats by inactivation of NF-kB. J Inflamm (Lond) 7(1):21. \nhttps:\/\/doi.org\/10.1186\/1476-9255-7-21.","journal-title":"J Inflamm (Lond)"},{"issue":"8","key":"2088_CR24","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1055\/s-2005-870317","volume":"37","author":"C Pantos","year":"2005","unstructured":"Pantos C, Paizis I, Mourouzis I, Moraitis P, Tzeis S, Karamanoli E, Mourouzis C, Karageorgiou H, Cokkinos DV (2005) Blockade of angiotensin II type 1 receptor diminishes cardiac hypertrophy, but does not abolish thyroxin-induced preconditioning. Horm Metab Res 37(8):500\u2013504. \nhttps:\/\/doi.org\/10.1055\/s-2005-870317","journal-title":"Horm Metab Res"},{"issue":"12","key":"2088_CR25","doi-asserted-by":"publisher","first-page":"6668","DOI":"10.1073\/pnas.111155798","volume":"98","author":"NH Purcell","year":"2001","unstructured":"Purcell NH, Tang G, Yu C, Mercurio F, DiDonato JA, Lin A (2001) Activation of NF-kappa B is required for hypertrophic growth of primary rat neonatal ventricular cardiomyocytes. Proc Natl Acad Sci U S A 98(12):6668\u20136673. \nhttps:\/\/doi.org\/10.1073\/pnas.111155798","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1-2","key":"2088_CR26","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1007\/s11010-012-1307-x","volume":"366","author":"V Rajapurohitam","year":"2012","unstructured":"Rajapurohitam V, Kilic A, Javadov S, Karmazyn M (2012) Role of NF-\u03baB and p38 MAPK activation in mediating angiotensin II and endothelin-1-induced stimulation in leptin production and cardiomyocyte hypertrophy. Mol Cell Biochem 366(1-2):287\u2013297. \nhttps:\/\/doi.org\/10.1007\/s11010-012-1307-x","journal-title":"Mol Cell Biochem"},{"issue":"9","key":"2088_CR27","doi-asserted-by":"publisher","first-page":"1927","DOI":"10.1097\/HJH.0b013e3281e66653","volume":"25","author":"B S\u00e1rm\u00e1n","year":"2007","unstructured":"S\u00e1rm\u00e1n B, Skoumal R, Leskinen H, Rys\u00e4 J, Ilves M, Soini Y, Tuukkanen J, Pikkarainen S, Lak\u00f3-Fut\u00f3 Z, S\u00e1rm\u00e1n B, Papp L, deCh\u00e2tel R, T\u00f3th M, Ruskoaho H, Szokodi I (2007) Nuclear factor-\u03baB signaling contributes to severe, but not moderate, angiotensin II-induced left ventricular remodeling. J Hypertens 25(9):1927\u20131939. \nhttps:\/\/doi.org\/10.1097\/HJH.0b013e3281e66653","journal-title":"J Hypertens"},{"issue":"3","key":"2088_CR28","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1161\/HYPERTENSIONAHA.115.06011","volume":"66","author":"MV Singh","year":"2015","unstructured":"Singh MV, Cicha MZ, Meyerholz DK, Chapleau MW, Abboud FM (2015) Dual activation of TRIF and MyD88 adaptor proteins by angiotensin II evokes opposing effects on pressure, cardiac hypertrophy, and inflammatory gene expression. Hypertension 66(3):647\u2013656. \nhttps:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.115.06011","journal-title":"Hypertension"},{"issue":"6","key":"2088_CR29","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1016\/S1357-2725(02)00271-6","volume":"35","author":"Y Suzuki","year":"2003","unstructured":"Suzuki Y, Ruiz-Ortega M, Lorenzo O, Ruperez M, Esteban V, Egido J (2003) Inflammation and angiotensin II. Int J Biochem Cell Biol 35(6):881\u2013900. \nhttps:\/\/doi.org\/10.1016\/S1357-2725(02)00271-6","journal-title":"Int J Biochem Cell Biol"},{"issue":"29","key":"2088_CR30","doi-asserted-by":"publisher","first-page":"22338","DOI":"10.1074\/jbc.M110.121749","volume":"285","author":"A Tadevosyan","year":"2010","unstructured":"Tadevosyan A, Maguy A, Villeneuve LR, Babin J, Bonnefoy A, Allen BG, Nattel S (2010) Nuclear-delimited angiotensin receptor-mediated signaling regulates cardiomyocyte gene expression. J Biol Chem 285(29):22338\u201322349. \nhttps:\/\/doi.org\/10.1074\/jbc.M110.121749","journal-title":"J Biol Chem"},{"issue":"6","key":"2088_CR31","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1007\/s00109-017-1511-y","volume":"95","author":"AP Takano","year":"2017","unstructured":"Takano AP, Munhoz CD, Moriscot AS, Gupta S, Barreto-Chaves ML (2017) S100A8\/MYD88\/NF-\u049bB: a novel pathway involved in cardiomyocyte hypertrophy driven by thyroid hormone. J Mol Med (Berl) 95(6):671\u2013682. \nhttps:\/\/doi.org\/10.1007\/s00109-017-1511-y","journal-title":"J Mol Med (Berl)"},{"issue":"1","key":"2088_CR32","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1530\/JOE-11-0349","volume":"213","author":"F Vargas","year":"2012","unstructured":"Vargas F, Rodr\u00edguez-G\u00f3mez I, Vargas-Tendero P, Jimenez E, Montiel M (2012) The renin-angiotensin system in thyroid disorders and its role in cardiovascular and renal manifestations. J Endocrinol 213(1):25\u201336. \nhttps:\/\/doi.org\/10.1530\/JOE-11-0349","journal-title":"J Endocrinol"},{"issue":"6","key":"2088_CR33","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1161\/HYPERTENSIONAHA.113.02843","volume":"63","author":"Y Wu","year":"2014","unstructured":"Wu Y, Li Y, Zhang C, A X, Wang Y, Cui W, Li H, Du J (2014) S100a8\/a9 released by CD11b+Gr1+ neutrophils activates cardiac fibroblasts to initiate angiotensin II-induced cardiac inflammation and injury. Hypertension 63(6):1241\u20131250. \nhttps:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.113.02843","journal-title":"Hypertension"},{"issue":"3","key":"2088_CR34","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1016\/j.jmb.2008.05.076","volume":"381","author":"D Young","year":"2008","unstructured":"Young D, Popovic ZB, Jones WK, Gupta S (2008) Blockade of NF-\u03baB using I\u03baB\u03b1 dominant-negative mice ameliorates cardiac hypertrophy in myotrophin-overexpressed transgenic mice. J Mol Biol 381(3):559\u2013568. \nhttps:\/\/doi.org\/10.1016\/j.jmb.2008.05.076","journal-title":"J Mol Biol"}],"container-title":["Pfl\u00fcgers Archiv - European Journal of Physiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00424-017-2088-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00424-017-2088-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00424-017-2088-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,2,8]],"date-time":"2018-02-08T05:00:04Z","timestamp":1518066004000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00424-017-2088-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11,25]]},"references-count":34,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,3]]}},"alternative-id":["2088"],"URL":"https:\/\/doi.org\/10.1007\/s00424-017-2088-6","relation":{},"ISSN":["0031-6768","1432-2013"],"issn-type":[{"value":"0031-6768","type":"print"},{"value":"1432-2013","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,11,25]]}}}